ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
Publication
, Journal Article
Douglas, SR; Thomas, SM; Chiba, A; DiNome, ML; DiLalla, GA; Hwang, ES; Parrish, KM; Rosenberger, LH; Plichta, JK; Wang, T; Botty van den Bruele, A
Published in: Ann Surg Oncol
February 2026
Duke Scholars
Published In
Ann Surg Oncol
DOI
EISSN
1534-4681
Publication Date
February 2026
Volume
33
Issue
2
Start / End Page
1248 / 1249
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Douglas, S. R., Thomas, S. M., Chiba, A., DiNome, M. L., DiLalla, G. A., Hwang, E. S., … Botty van den Bruele, A. (2026). ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery. Ann Surg Oncol, 33(2), 1248–1249. https://doi.org/10.1245/s10434-025-18393-4
Douglas, Sasha R., Samantha M. Thomas, Akiko Chiba, Maggie L. DiNome, Gayle A. DiLalla, E Shelley Hwang, Kendra Modell Parrish, et al. “ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.” Ann Surg Oncol 33, no. 2 (February 2026): 1248–49. https://doi.org/10.1245/s10434-025-18393-4.
Douglas SR, Thomas SM, Chiba A, DiNome ML, DiLalla GA, Hwang ES, et al. ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery. Ann Surg Oncol. 2026 Feb;33(2):1248–9.
Douglas, Sasha R., et al. “ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.” Ann Surg Oncol, vol. 33, no. 2, Feb. 2026, pp. 1248–49. Pubmed, doi:10.1245/s10434-025-18393-4.
Douglas SR, Thomas SM, Chiba A, DiNome ML, DiLalla GA, Hwang ES, Parrish KM, Rosenberger LH, Plichta JK, Wang T, Botty van den Bruele A. ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery. Ann Surg Oncol. 2026 Feb;33(2):1248–1249.
Published In
Ann Surg Oncol
DOI
EISSN
1534-4681
Publication Date
February 2026
Volume
33
Issue
2
Start / End Page
1248 / 1249
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis